PML-dependent apoptosis after DNA damage is regulated by the checkpoint kinase hCds1/Chk2
暂无分享,去创建一个
[1] T. Jacks,et al. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2 , 1994, Cell.
[2] Stephen J. Elledge,et al. Cell Cycle Checkpoints: Preventing an Identity Crisis , 1996, Science.
[3] J. Bartek,et al. Chk2 kinase — a busy messenger , 2001, Nature Reviews Molecular Cell Biology.
[4] Jong-Soo Lee,et al. hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response , 2000, Nature.
[5] H. Piwnica-Worms,et al. A human Cds1-related kinase that functions downstream of ATM protein in the cellular response to DNA damage. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[6] S. Elledge,et al. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. , 2000, Science.
[7] P. Freemont,et al. Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. , 1991, Science.
[8] T. Halazonetis,et al. Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. , 2000, Genes & development.
[9] Junjie Chen,et al. Threonine 68 of Chk2 Is Phosphorylated at Sites of DNA Strand Breaks* , 2001, The Journal of Biological Chemistry.
[10] P. Pandolfi,et al. A role for PML and the nuclear body in genomic stability , 1999, Oncogene.
[11] Christine Chomienne,et al. The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR , 1991, Cell.
[12] Jing Chen,et al. Characterization of Tumor-associated Chk2 Mutations* , 2001, The Journal of Biological Chemistry.
[13] G. Lozano,et al. PML, a growth suppressor disrupted in acute promyelocytic leukemia , 1994, Molecular and cellular biology.
[14] J. Bartek,et al. Chk2 tumour suppressor protein in human spermatogenesis and testicular germ-cell tumours , 2001, Oncogene.
[15] E. Clementi,et al. TNFalpha enhances the DNA single-strand breakage induced by the short-chain lipid hydroperoxide analogue tert-butylhydroperoxide via ceramide-dependent inhibition of complex III followed by enforced superoxide and hydrogen peroxide formation. , 2001, Experimental cell research.
[16] H. Bartelink,et al. Alkyl-lysophospholipids activate the SAPK/JNK pathway and enhance radiation-induced apoptosis. , 1999, Cancer research.
[17] Ailan Guo,et al. The function of PML in p53-dependent apoptosis , 2000, Nature Cell Biology.
[18] M. Koken,et al. PML induces a novel caspase-independent death process , 1998, Nature Genetics.
[19] T. Taniguchi,et al. An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes , 1995, Nature.
[20] P. Pandolfi,et al. Role of PML in cell growth and the retinoic acid pathway. , 1998, Science.
[21] C. Potten,et al. Apoptosis in small intestinal epithelia from p53-null mice: evidence for a delayed, p53-indepdendent G2/M-associated cell death after γ-irradiation , 1997, Oncogene.
[22] K. Isselbacher,et al. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. , 1999, Science.
[23] L. Chung,et al. Adenovirus-mediated expression of PML suppresses growth and tumorigenicity of prostate cancer cells. , 1997, Cancer research.
[24] Y Taya,et al. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. , 2000, Genes & development.
[25] S. Parodi,et al. Potentiation of Topoisomerase I and II Inhibitors Cell Killing by Tumor Necrosis Factor: Relationship to DNA Strand Breakage Formation , 1992, Japanese journal of cancer research : Gann.
[26] M Alcalay,et al. Alternative splicing of PML transcripts predicts coexpression of several carboxy-terminally different protein isoforms. , 1992, Oncogene.
[27] P. Pandolfi,et al. Pml is essential for multiple apoptotic pathways , 1998, Nature Genetics.
[28] N. Mailand,et al. The ATM–Chk2–Cdc25A checkpoint pathway guards against radioresistant DNA synthesis , 2001, Nature.
[29] V. Rotter,et al. Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[30] A. Zelent,et al. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia. , 1998, Blood.
[31] X. Le,et al. Stable overexpression of PML alters regulation of cell cycle progression in HeLa cells. , 1997, Carcinogenesis.
[32] N. Mailand,et al. DNA damage-activated kinase Chk2 is independent of proliferation or differentiation yet correlates with tissue biology. , 2001, Cancer research.
[33] K. Mori,et al. Nitric Oxide-induced Apoptosis in RAW 264.7 Macrophages Is Mediated by Endoplasmic Reticulum Stress Pathway Involving ATF6 and CHOP* , 2002, The Journal of Biological Chemistry.
[34] Koichi Sugimoto,et al. Frequent mutations in the p53 gene in human myeloid leukemia cell lines. , 1992, Blood.
[35] S. Elledge,et al. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. , 1998, Science.
[36] K. Umesono,et al. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML , 1991, Cell.
[37] J. Bisi,et al. Dominant-negative polo-like kinase 1 induces mitotic catastrophe independent of cdc25C function. , 2000, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[38] M. Hung,et al. Recombinant PML adenovirus suppresses growth and tumorigenicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosis , 1998, Oncogene.
[39] P. Pandolfi,et al. Promyelocytic Leukemia Protein (Pml) and Daxx Participate in a Novel Nuclear Pathway for Apoptosis , 2000, The Journal of experimental medicine.